共 48 条
- [46] Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study Annals of Nuclear Medicine, 2022, 36 : 1039 - 1049
- [47] Evaluation of plasma amyloid peptides Aβ1-40 and Aβ1-42 as diagnostic biomarker of alzheimer's disease, its association with different grades of clinical severity and 18f-fluorodeoxyglucose positron emission tomography Z score in the Indian population: A case-control study INDIAN JOURNAL OF NUCLEAR MEDICINE, 2021, 36 (04): : 391 - 397